Sign In
Buy SOLV
$74.56
-2.00 (-2.61%)
At Close: Jun 17, 2026
Solventum to Participate in the Piper Sandler Healthcare Conference
06:50am, Tuesday, 19'th Nov 2024
ST. PAUL, Minn., Nov. 19, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its executives will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on
SOLV Stock Falls Despite Launch of Clarity Precision Grip Attachments
08:50am, Friday, 15'th Nov 2024
Solventum's Clarity precision grip attachments enhance treatment outcomes for orthodontic patients, reducing the risk of misplaced and malformed attachments.
Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment
09:00am, Thursday, 14'th Nov 2024
Clarity Precision Grip Attachments are fully cured, pre-loaded and precisely resemble the digital treatment plan after bonding ST. PAUL, Minn.
Solventum Corporation (SOLV) Q3 2024 Earnings Call Transcript
05:16pm, Friday, 08'th Nov 2024
Solventum Corporation (NYSE:SOLV ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Kevin Moran - SVP, IR Bryan Hanson - CEO Wayde McMillan - CFO Conference Call Parti
SOLV Stock Gains as Q3 Earnings & Sales Beat Estimates, '24 View Up
09:31am, Friday, 08'th Nov 2024
Solventum's top line reflects the favorable impact of pricing normalization. Organic growth is primarily driven by rising demand for MedSurg products.
Solventum raises annual profit forecast on strong surgical product sales
04:47pm, Thursday, 07'th Nov 2024
3M spin-off Solventum raised its annual profit forecast on Thursday, betting on strong sales of its wound care and surgical sterilization products.
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance
04:05pm, Thursday, 07'th Nov 2024
Reported sales increased 0.4% to $2.082 billion; organic sales increased 0.3% GAAP Earnings Per Share (EPS) of $0.70; adjusted EPS1 of $1.64 Generated $169 million in cash from operations; free cash f
Solventum Q3 Earnings Likely to Reflect Declining Volume Trend
08:55am, Wednesday, 06'th Nov 2024
SOLV's Q3 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset sales decline.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Monday, 04'th Nov 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Solventum Taps Bankers to Explore Sale of Filtration Unit
11:33am, Thursday, 24'th Oct 2024
The business is expected to draw takeover interest from private equity and strategic buyers.
Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Tuesday, 15'th Oct 2024
Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
06:50am, Tuesday, 15'th Oct 2024
ST. PAUL, Minn. , Oct. 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets close.
Solventum Announces Commitment to 100% Renewable Electricity by 2030
07:00am, Monday, 14'th Oct 2024
ST. PAUL, Minn. , Oct. 14, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today pledges to use 100% renewable electricity across its worldwide operations by 2030.
Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer
09:00am, Thursday, 10'th Oct 2024
ST. PAUL, Minn. , Oct. 10, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that Dr. Ryan Egeland, MD, has been named chief medical officer.
Buy 4 October Dividend Aristocrats & Watch 10
12:17pm, Wednesday, 09'th Oct 2024
"Dividend Aristocrats... in the S&P500 Index… have raised their annual payouts every year for at least 25 consecutive years." -- Kiplinger.com/Investing. 67 Aristocrats, screened as of October 7, 20
